The cost effectiveness of prenatal ultrasound screening for Trisomy 21
The objective of this paper is to compare the cost effectiveness of opportunistic nuchal translucency ultrasound screening in pregnancy with alternative screening strategies for trisomy 21 in Australia. Methods used is a decision analytic model of various pregnancy screening strategies based on a systematic review of the literature on the effectiveness of nuchal translucency ultrasound and serum screening and costs based on current reimbursement fees. The model included the likelihood and cost of terminations following diagnostic testing and the associated risk of fetal loss. All prices are in 2001 Australian dollars.
|Date of creation:||Oct 2003|
|Date of revision:|
|Contact details of provider:|| Postal: Centre for Health Economics, Monash University, Building 75, Clayton, Victoria 3800, Australia|
Web page: http://www.buseco.monash.edu.au/centres/che/
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:mhe:chewps:2004-146. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Teresa Cheong)
If references are entirely missing, you can add them using this form.